FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular to cardiovascular surgery, and is intended to predict the development of critical ischemia up to 5 years from the onset of the disease with obliterating atherosclerosis of the arteries of the lower extremities. Genotyping of polymorphism -250 G>A of the LIPC gene is carried out. If a heterozygous carrier is detected, an increased risk of developing critical ischemia is predicted for up to 5 years from the onset of the disease with obliterating atherosclerosis of the arteries of the lower extremities.
EFFECT: invention provides the development of a method for predicting the unfavorable type of course of obliterating atherosclerosis of the arteries of the lower extremities.
1 cl, 1 tbl, 2 ex
